Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-075486

Director acquired 5,345 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ray Amrit Director 2024-06-18 Grant or award +5,345 17,625 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ray Amrit Director 2024-06-18 Grant or award · Stock Option (Right to Buy) +9,900 9,900 D: show line 2 in the form
Loading xslF345X05/ownership.xml…